Cargando…

Clinical Significance of Soluble Hemoglobin Scavenger Receptor CD163 (sCD163) in Sepsis, a Prospective Study

OBJECTIVE: We investigated serum soluble CD163 (sCD163) levels for use in the diagnosis, severity assessment, and prognosis of sepsis in the critical ill patients and compared sCD163 with other infection-related variables. METHODS: During july 2010 and April 2011, serum was obtained from 102 sepsis...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Lin, Zhou, Xin, Su, Long-Xiang, Feng, Dan, Jia, Yan-Hong, Xie, Li-Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401183/
https://www.ncbi.nlm.nih.gov/pubmed/22911680
http://dx.doi.org/10.1371/journal.pone.0038400
_version_ 1782238579874856960
author Feng, Lin
Zhou, Xin
Su, Long-Xiang
Feng, Dan
Jia, Yan-Hong
Xie, Li-Xin
author_facet Feng, Lin
Zhou, Xin
Su, Long-Xiang
Feng, Dan
Jia, Yan-Hong
Xie, Li-Xin
author_sort Feng, Lin
collection PubMed
description OBJECTIVE: We investigated serum soluble CD163 (sCD163) levels for use in the diagnosis, severity assessment, and prognosis of sepsis in the critical ill patients and compared sCD163 with other infection-related variables. METHODS: During july 2010 and April 2011, serum was obtained from 102 sepsis patients (days 1, 3, 5, 7, and 10 after admission to an ICU) and 30 systemic inflammatory response syndrome (SIRS) patients with no sepsis diagnosed. Serum levels of sCD163, procalcitonon (PCT), and C reactive protein (CRP) were determined respectively. Sequential organ failure assessment (SOFA) scores for sepsis patients were also recorded. Then evaluated their roles in sepsis. RESULTS: The sCD163 levels were 0.88(0.78–1.00)ug/mL for SIRS patients, 1.50(0.92–2.00)ug/mL for moderate sepsis patients, and 2.95(2.18–5.57)ug/mL for severe sepsis patients on day1. The areas under the ROC curves for sCD163, CRP, and PCT for the diagnosis of sepsis were, respectively, 0.856(95%CI: 0.791–0.921), 0.696(95%CI: 0.595–0.797), and 0.629(95%CI: 0.495–0.763), At the recommended cut-off 1.49 ug/mL for sCD163, the sensitivity is 74.0% with 93.3% specificity. Based on 28-day survivals, sCD163 levels in the surviving group stay constant, while they tended to gradually increase in the non-surviving group.The area under the ROC curve for sCD163 for sepsis prognosis was 0.706(95%CI 0.558–0.804). Levels of sCD163 with cut-off point >2.84 ug/mL have sensitivity of 55.8.0%, specificity 80.4%.Common risk factors for death and sCD163 were included in multivariate logistic regression analysis; the odds ratios (OR) for sCD163 and SOFA scores for sepsis prognosis were 1.173 and 1.396, respectively (P<0.05). Spearman rank correlation analysis showed that sCD163 was weakly, but positively correlated with CRP, PCT, and SOFA scores (0.2< r <0.4, P<0.0001), but not with leukocyte counts (r <0.2, P = 0.450). CONCLUSION: Serum sCD163 is superior to PCT and CRP for the diagnosis of sepsis and differentiate the severity of sepsis. sCD163 levels were more sensitive for dynamic evaluations of sepsis prognosis. Serum sCD163 and SOFA scores are prognostic factors for sepsis. TRIAL REGISTRATION: www.chictr.org ChiCTR-ONC-10000812
format Online
Article
Text
id pubmed-3401183
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-34011832012-07-30 Clinical Significance of Soluble Hemoglobin Scavenger Receptor CD163 (sCD163) in Sepsis, a Prospective Study Feng, Lin Zhou, Xin Su, Long-Xiang Feng, Dan Jia, Yan-Hong Xie, Li-Xin PLoS One Research Article OBJECTIVE: We investigated serum soluble CD163 (sCD163) levels for use in the diagnosis, severity assessment, and prognosis of sepsis in the critical ill patients and compared sCD163 with other infection-related variables. METHODS: During july 2010 and April 2011, serum was obtained from 102 sepsis patients (days 1, 3, 5, 7, and 10 after admission to an ICU) and 30 systemic inflammatory response syndrome (SIRS) patients with no sepsis diagnosed. Serum levels of sCD163, procalcitonon (PCT), and C reactive protein (CRP) were determined respectively. Sequential organ failure assessment (SOFA) scores for sepsis patients were also recorded. Then evaluated their roles in sepsis. RESULTS: The sCD163 levels were 0.88(0.78–1.00)ug/mL for SIRS patients, 1.50(0.92–2.00)ug/mL for moderate sepsis patients, and 2.95(2.18–5.57)ug/mL for severe sepsis patients on day1. The areas under the ROC curves for sCD163, CRP, and PCT for the diagnosis of sepsis were, respectively, 0.856(95%CI: 0.791–0.921), 0.696(95%CI: 0.595–0.797), and 0.629(95%CI: 0.495–0.763), At the recommended cut-off 1.49 ug/mL for sCD163, the sensitivity is 74.0% with 93.3% specificity. Based on 28-day survivals, sCD163 levels in the surviving group stay constant, while they tended to gradually increase in the non-surviving group.The area under the ROC curve for sCD163 for sepsis prognosis was 0.706(95%CI 0.558–0.804). Levels of sCD163 with cut-off point >2.84 ug/mL have sensitivity of 55.8.0%, specificity 80.4%.Common risk factors for death and sCD163 were included in multivariate logistic regression analysis; the odds ratios (OR) for sCD163 and SOFA scores for sepsis prognosis were 1.173 and 1.396, respectively (P<0.05). Spearman rank correlation analysis showed that sCD163 was weakly, but positively correlated with CRP, PCT, and SOFA scores (0.2< r <0.4, P<0.0001), but not with leukocyte counts (r <0.2, P = 0.450). CONCLUSION: Serum sCD163 is superior to PCT and CRP for the diagnosis of sepsis and differentiate the severity of sepsis. sCD163 levels were more sensitive for dynamic evaluations of sepsis prognosis. Serum sCD163 and SOFA scores are prognostic factors for sepsis. TRIAL REGISTRATION: www.chictr.org ChiCTR-ONC-10000812 Public Library of Science 2012-07-20 /pmc/articles/PMC3401183/ /pubmed/22911680 http://dx.doi.org/10.1371/journal.pone.0038400 Text en Feng et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Feng, Lin
Zhou, Xin
Su, Long-Xiang
Feng, Dan
Jia, Yan-Hong
Xie, Li-Xin
Clinical Significance of Soluble Hemoglobin Scavenger Receptor CD163 (sCD163) in Sepsis, a Prospective Study
title Clinical Significance of Soluble Hemoglobin Scavenger Receptor CD163 (sCD163) in Sepsis, a Prospective Study
title_full Clinical Significance of Soluble Hemoglobin Scavenger Receptor CD163 (sCD163) in Sepsis, a Prospective Study
title_fullStr Clinical Significance of Soluble Hemoglobin Scavenger Receptor CD163 (sCD163) in Sepsis, a Prospective Study
title_full_unstemmed Clinical Significance of Soluble Hemoglobin Scavenger Receptor CD163 (sCD163) in Sepsis, a Prospective Study
title_short Clinical Significance of Soluble Hemoglobin Scavenger Receptor CD163 (sCD163) in Sepsis, a Prospective Study
title_sort clinical significance of soluble hemoglobin scavenger receptor cd163 (scd163) in sepsis, a prospective study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401183/
https://www.ncbi.nlm.nih.gov/pubmed/22911680
http://dx.doi.org/10.1371/journal.pone.0038400
work_keys_str_mv AT fenglin clinicalsignificanceofsolublehemoglobinscavengerreceptorcd163scd163insepsisaprospectivestudy
AT zhouxin clinicalsignificanceofsolublehemoglobinscavengerreceptorcd163scd163insepsisaprospectivestudy
AT sulongxiang clinicalsignificanceofsolublehemoglobinscavengerreceptorcd163scd163insepsisaprospectivestudy
AT fengdan clinicalsignificanceofsolublehemoglobinscavengerreceptorcd163scd163insepsisaprospectivestudy
AT jiayanhong clinicalsignificanceofsolublehemoglobinscavengerreceptorcd163scd163insepsisaprospectivestudy
AT xielixin clinicalsignificanceofsolublehemoglobinscavengerreceptorcd163scd163insepsisaprospectivestudy